216 related articles for article (PubMed ID: 26973297)
1. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
[TBL] [Abstract][Full Text] [Related]
2. Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015.
Schjøtt J
Aging Clin Exp Res; 2018 Jul; 30(7):867-870. PubMed ID: 28929445
[TBL] [Abstract][Full Text] [Related]
3. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.
Widnes SF; Schjøtt J; Eide GE; Granas AG
Drug Saf; 2013 Jun; 36(6):481-9. PubMed ID: 23539202
[TBL] [Abstract][Full Text] [Related]
4. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
[TBL] [Abstract][Full Text] [Related]
5. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
[TBL] [Abstract][Full Text] [Related]
6. Risk perception regarding drug use in pregnancy.
Widnes SF; Schjøtt J
Am J Obstet Gynecol; 2017 Apr; 216(4):375-378. PubMed ID: 27988271
[TBL] [Abstract][Full Text] [Related]
7. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.
Fadare JO; Adeoti AO; Desalu OO; Enwere OO; Makusidi AM; Ogunleye O; Sunmonu TA; Truter I; Akunne OO; Godman B
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):639-650. PubMed ID: 26567041
[TBL] [Abstract][Full Text] [Related]
8. A teachable moment for providers and patients alike: contraceptive counseling when prescribing medications with teratogenic potential.
Gottlieb AS
J Womens Health (Larchmt); 2013 Oct; 22(10):795-6. PubMed ID: 24044697
[No Abstract] [Full Text] [Related]
9. Counseling about medication-induced birth defects with clinical decision support in primary care.
Schwarz EB; Parisi SM; Handler SM; Koren G; Shevchik G; Fischer GS
J Womens Health (Larchmt); 2013 Oct; 22(10):817-24. PubMed ID: 23930947
[TBL] [Abstract][Full Text] [Related]
10. Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study.
Rohra DK; Das N; Azam SI; Solangi NA; Memon Z; Shaikh AM; Khan NH
BMC Pregnancy Childbirth; 2008 Jul; 8():24. PubMed ID: 18627607
[TBL] [Abstract][Full Text] [Related]
11. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
[TBL] [Abstract][Full Text] [Related]
12. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
[TBL] [Abstract][Full Text] [Related]
13. Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries.
Cantilino A; Lorenzo L; Paula Jdos A; Einarson A
Braz J Psychiatry; 2014; 36(2):106-10. PubMed ID: 24676044
[TBL] [Abstract][Full Text] [Related]
14. Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.
Schjøtt J; Erdal H
BMC Complement Altern Med; 2014 Feb; 14():56. PubMed ID: 24529279
[TBL] [Abstract][Full Text] [Related]
15. Perception of prescribing factors and purchase statistics of non-steroidal anti-inflammatory drugs in an orthopedic clinic.
Schjøtt J; Erdal H; Opskar S; Bjånes TK
BMC Res Notes; 2020 Feb; 13(1):100. PubMed ID: 32093756
[TBL] [Abstract][Full Text] [Related]
16. [Generic drugs: good or bad? Physician's knowledge of generic drugs and prescribing habits].
García AJ; Martos F; Leiva F; Sánchez de la Cuesta F
Gac Sanit; 2003; 17(2):144-9. PubMed ID: 12729542
[TBL] [Abstract][Full Text] [Related]
17. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
[TBL] [Abstract][Full Text] [Related]
18. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM
Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185
[TBL] [Abstract][Full Text] [Related]
19. [Prescribed and dispensed in the third trimester of pregnancy drugs: What practices and risks?].
Parent G; Mottet N; Mairot P; Baudier F; Carel D; Goguey M; Riethmuller D; Limat S
J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):754-9. PubMed ID: 26481682
[TBL] [Abstract][Full Text] [Related]
20. Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.
Jahnsen JA; Widnes SF; Schjøtt J
Int Breastfeed J; 2018; 13():1. PubMed ID: 29339968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
